Dun***son

Director Business Development

Éducation

University of Oxford

University of Oxford (2011 - 2015)

  • Degree: Doctor of Philosophy (PhD)
  • Field of Study: Pathology
  • Description:

University of Pretoria/Universiteit van Pretoria (2009 - 2011)

  • Degree: Master of Science (MSc)
  • Field of Study: Microbiology
  • Description:

University of Pretoria/Universiteit van Pretoria (2005 - 2009)

  • Degree: BSc (Hons)
  • Field of Study: Microbiology
  • Description:

Compétences :

Expérience professionnelle :

Director Business Development at Amgen

  • Location: Greater Los Angeles, California, United States
  • Duration: 2023-07 to Present
  • Description:

Senior Manager, Business Development at Amgen

  • Location: Thousand Oaks, California, United States
  • Duration: 2020-04 to 2023-07
  • Description: Deal-making to access next-generation technologies for discovering and developing new medicines. 50+ deals across multiple technology and therapeutic areas. Selected publicly disclosed deals: 𝐀𝐫𝐫𝐚𝐤𝐢𝐬 - 𝐀𝐦𝐠𝐞𝐧: Multi-target collaboration to discover small molecule RNA degraders 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐁𝐢𝐨𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 - 𝐀𝐦𝐠𝐞𝐧: Multi-target collaboration to utilize Generate's machine-learning approach for discovery of biologics 𝐄𝐕𝐎𝐐 - 𝐀𝐦𝐠𝐞𝐧: Multi-target collaboration to enable tolerance induction in auto-immune diseases 𝐆𝐑𝐀𝐈𝐋 - 𝐀𝐦𝐠𝐞𝐧: Collaboration to determine patient tumor burden from liquid biopsy derived cfDNA methylation signatures

Director of Product Management at Integral Molecular

  • Location: Greater Philadelphia Area
  • Duration: 2019-01 to 2020-04
  • Description: Lead business development and partnerships for the Membrane Proteome Array - a novel high-throughput platform for novel drug target discovery in therapeutic areas including oncology, auto-immunity and infectious disease. Oversaw restructuring of product and marketing portfolios and alignment with commercial strategy General Manager of a wholly-owned division founded to commercialize certain aspects of the Membrane Proteome Array platform.

Product Manager at Integral Molecular

  • Location: Greater Philadelphia Area
  • Duration: 2015-11 to 2018-12
  • Description: Led the team that developed and commercialized the Membrane Proteome Array (MPA) - an innovative high-throughput screening platform Responsible for commercial strategy of the MPA service business based around off-target screening of biologics to de-risk clinical development. Responsible for overseeing business development and partnerships using the MPA for novel drug target discovery in therapeutic areas including oncology, auto-immunity and infectious disease.

DPhil Student at University of Oxford

  • Location: Oxford, United Kingdom
  • Duration: 2011-10 to 2015-12
  • Description: DPhil in Pathology supervised by Prof. Ervin Fodor at The Sir William Dunn School of Pathology Title: Influenza A Virus: Host Restriction of the Viral Polymerase and a Mechanism for vRNP Nuclear Export Publications: Paterson, D. & Fodor, E. Emerging Roles for the Influenza A Virus Nuclear Export Protein (NEP). PLoS Pathog. 8, e1003019 (2012). Paterson, D., te Velthuis, A. J. W., Vreede, F. T. & Fodor, E. Host restriction of influenza virus polymerase activity by PB2 627E is diminished on short viral templates in a nucleoprotein-independent manner. J. Virol. 88, 339–344 (2014). Resa-Infante, P., Paterson, D. et al. Targeting importin-α7 as a therapeutic approach against pandemic influenza viruses. J. Virol. (2015).
Analyse de CV par IA

Rapport d'intelligence candidat

Analyse alimentée par l'IA du point de vue d'un directeur de recrutement américain — évaluant la continuité de carrière, la trajectoire de croissance et l'adéquation au poste.

Continuité de carrière et évaluation des risques

Employment GapLow

No significant employment gaps; continuous progression from 2015 through present. A minimal 1-month gap between 2018-12 and 2019-01 is offset by immediate return to employment.

Industry ConsistencyLow

Career remains within biotech/pharma and drug discovery ecosystems (Integral Molecular, Amgen); strong alignment with life sciences deal-making and partnerships.

Tenure StabilityLow

Demonstrated stable tenure with progressive responsibility: multi-year periods at Integral Molecular and consistent promotions at Amgen, indicating low turnover risk.

Education-Career MatchLow

Oxford DPhil in Pathology provides a rigorous scientific foundation that complements and supports advanced BD, partnerships, and product strategy in biotech/pharma.

Courbe de croissance de carrière

Product Manager Entry
Integral Molecular
2015-11 to 2018-12
Director of Product Management ↑ Promu
Integral Molecular
2019-01 to 2020-04
Senior Manager, Business Development ↑ Promu
Amgen
2020-04 to 2023-07
Director Business Development ↑ Promu
Amgen
2023-07 to Present
Évaluation :The candidate shows a coherent upward trajectory within high-profile biotech environments, with increasing scope in deal-making and platform partnerships. Ready for senior leadership in Corporate Development or Strategic Partnerships (e.g., VP/SVP level); would benefit from broader P&L exposure and people leadership to accelerate to the very top executive roles.

Rôles les mieux adaptés (Top 5)

1

Vice President, Corporate Development & Alliances95% adéquation

Proven track record of leading high-value deals and strategic partnerships across multiple platforms, with current Amgen BD leadership experience.

2

Senior Vice President, Strategic Partnerships92% adéquation

Extensive deal-making history (50+ deals) and cross-therapy/technology collaboration experience; aligns with global partnership strategy at scale.

3

Head of Strategic Partnerships90% adéquation

Strong partnership management and product-BD integration background; suitable for leading a partner ecosystem in a growth-stage or established biotech.

4

Director/Head of Corporate Development86% adéquation

Direct experience in deal structuring and portfolio strategy; natural progression for a leader aiming to run BD/CORP Dev for a mid-to-large biotech.

5

Global Partnerships Director83% adéquation

Experience with multinational collaborators and a global deal lens; suitable for roles focusing on global BD and alliance networks.

Découvrez AI Recruiter

Commencez à 0 $. Ne laissez pas vos concurrents obtenir l'avantage de l'IA en premier.

Rejoignez plus de 10 000 entreprises utilisant des solutions de recrutement basées sur l'IA pour automatiser votre processus d'embauche et économiser 80% du temps.

33% de réduction, plus que 48 heures !
Essayez l'IA gratuitement

Opération automatisée 24h/24 et 7j/7

Sélection des candidats par IA

Recrutement sans limites géographiques ou de fuseau horaire

Communication intelligente personnalisée

Évaluation automatisée de l'engagement des candidats

Imite et reproduit intelligemment votre style de recrutement

Garantie de remboursement de 4 mois

Assure la sécurité du compte LinkedIn